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Abstract
Objective: We evaluated the early impact of COVID-19 on people with self-reported
eating disorders.
Method: Participants in the United States (US, N = 511) and the Netherlands (NL,
N = 510), recruited through ongoing studies and social media, completed an online
survey that included both quantitative measures and free-text responses assessing
the impact of COVID-19 on situational circumstances, eating disorder symptoms,
eating disorder treatment, and general well-being.
Results: Results revealed strong and wide-ranging effects on eating disorder concerns and
illness behaviors that were consistent with eating disorder type. Participants with anorexia
nervosa (US 62% of sample; NL 69%) reported increased restriction and fears about being
able to find foods consistent with their meal plan. Individuals with bulimia nervosa and
binge-eating disorder (US 30% of sample; NL 15%) reported increases in their binge-eating
episodes and urges to binge. Respondents noted marked increases in anxiety since 2019
and reported greater concerns about the impact of COVID-19 on their mental health than
physical health. Although many participants acknowledged and appreciated the transition
to telehealth, limitations of this treatment modality for this population were raised. Individ-
uals with past histories of eating disorders noted concerns about relapse related to
COVID-19 circumstances. Encouragingly, respondents also noted positive effects including
greater connection with family, more time for self-care, and motivation to recover.
Discussions: COVID-19 is associated with increased anxiety and poses specific
disorder-related challenges for individuals with eating disorders that require attention
by healthcare professionals and carers.
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1 | IMPACT OF COVID-19 ON
INDIVIDUALS WITH EATING DISORDERS
The novel coronavirus pandemic (COVID-19) has far-reaching effects
on both physical and mental health. Many aspects of the pandemic
are already adversely influencing mental health—the disease itself,
restrictive policies aimed at reducing the spread of COVID-19, eco-
nomic consequences, and more. A third of Americans were showing
signs of clinical anxiety or depression by late May 2020 (Fowers &
Wan, 2020). Addressing mental health needs is an integral part of the
COVID-19 response (Adhanom Ghebreyesus, 2020). Factors related
to COVID-19 will affect mental health in the general community
(Twenge & Joiner, 2020), but may have greater adverse effects on
individuals with pre-existing mental illnesses (Galletly, 2020; Kaufman,
Petkova, Bhui, & Schulze, 2020; The Lancet Psychiatry, 2020).
Reports from China suggest that those with psychiatric illnesses
before COVID-19 experienced a worsening in depression, anxiety,
and post-traumatic stress symptoms during the peak of the outbreak
(Hao et al., 2020; Liu et al., 2020; Wang et al., 2020; Zhou, Liu, Xue,
Yang, & Tang, 2020).
Individuals with eating disorders may face unique risks secondary
to the pandemic. Public health measures designed to flatten the curve,
and the impact of COVID-19 on food availability may directly and
adversely affect the core symptoms of eating disorders, including die-
tary restriction, binge eating, and compensatory behaviors. Interviews
with patients highlight issues such as intense urges to binge in those
with binge-eating disorder (BED) when high-risk foods are being
stockpiled to guard against disruptions to the food supply, anxiety
about food availability for those with anorexia nervosa (AN) or
avoidant/restrictive food intake disorder (ARFID), and changes in the
availability of treatment and social supports, isolation, and economic
factors interfering with treatment progress or precipitating relapse
(Goldberg, 2020; Hensley, 2020; McMenemy, 2020).
Specialist clinicians have highlighted the importance of attending
to the unique needs of patients with eating disorders during this time
(Fernández-Aranda et al., 2020; Phillipou et al., 2020; Shah, Sachdeva, &
Johnston, 2020; Touyz, Lacey, & Hay, 2020; Weissman, Bauer, &
Thomas, 2020; Yahya & Khawaja, 2020) and introduced potential adap-
tations to existing evidence-based interventions in inpatient (Davis
et al., 2020) and outpatient (Murphy, Calugi, Cooper, & Dalle
Grave, 2020; Waller et al., 2020) levels of care. However, the need for
data-driven information from individuals with lived experience is urgent
to guide clinicians in how best to deliver needed services.
One study (Fernández-Aranda et al., 2020) surveyed 32 patients
with eating disorders in Spain about the impact of physical distancing
measures during the first 2 weeks of confinement. They also reported
qualitative data from a multifamily chat group in the United Kingdom
consisting of eight patients with AN and their carers (Fernández-Aranda
et al., 2020). Patients in both groups reported exacerbation of their eat-
ing disorder symptoms, increased anxiety, and challenges associated with
reduced contact with their treatment teams, suggesting that patients
with eating disorders may be at risk for symptom exacerbation and/or
difficulty maintaining treatment progress during the global pandemic.
The objective of this study was to characterize the impact of
COVID-19 on patients with self-reported eating disorders and to
describe their treatment needs. Resultant data will inform best prac-
tices for clinicians and caregivers and provide a roadmap for eating
disorders care during the evolving pandemic as well as other cata-
strophic events that could interrupt direct service delivery.
2 | METHODS
2.1 | Participants and procedure
Participants from the United States (US) and the Netherlands (NL) were
invited to take part in an online study. US participants were recruited
via social media (e.g., Facebook, Twitter, Instagram advertisements, and
the UNC Exchanges blog), or via emails to participants who consented
to recontact from ongoing studies (Bulik et al., 2020; Thornton
et al., 2018). NL participants were also recruited via social media and
via the online platform Proud2Bme and the Dutch Eating Disorder Reg-
ister (NER). The minimum age to participate without parental consent
was 18 years in the US and 16 years in NL. Participants were
onboarded during a 29 day period from April 8, 2020 up to and includ-
ing May 6, 2020 in the US, and from April 17 up to and including May
15 in NL. For context, both surveys were launched early during the
COVID-19 pandemic—April 8, 2020 in US, and April 17, 2020 in
NL. The countries were in different stages of the pandemic and had dif-
ferent approaches to controlling contagion. In the US, the first patient
was diagnosed on January 20, 2020, with 1,204 confirmed cases per
million on April 8, 2020. In the US, responses and restrictions varied
considerably by state (e.g., lockdown, shelter-in-place, physical distanc-
ing). In NL, the first patient was diagnosed on February 27, 2020, initial
restrictive measures were active from March 12, and were prolonged
and intensified thereafter.
Consenting participants completed an online survey and agreed
to be recontacted approximately monthly on 12 occasions over the
course of a year. No compensation for participation was offered. Ethi-
cal approval was granted by the University of North Carolina Biomedi-
cal Institutional Review Board. The Medical Research Ethics
Committee (MREC-LDD) of Leiden University Medical Centre
reviewed the study protocol and confirmed that the Medical Research
Involving Human Subjects Act (WMO) did not apply to this study and
official approval of this study by the METC was not required.
2.2 | Measures
The online survey addressed concerns and challenges participants are
facing with regard to their eating disorder and general mental health
during the COVID-19 global pandemic. The survey was developed in
English, and translated to Dutch (see Supporting Information). The
survey was administered using Qualtrics in the US and SurveyMonkey
in NL. In the US, the Qualtrics survey options limiting responses to
one per IP address and preventing indexing were enabled.
2.2.1 | Sociodemographics and illness status
Participants reported their age, sex, gender identity, and geographic
location (US participants). Lifetime eating disorder diagnoses and cur-
rent illness status were self-reported.
2.2.2 | COVID-19 exposure and situational
circumstances
Several questions captured COVID-19 exposure (exposure to the
virus, diagnosis in self or family, and impact of COVID-19 on family
members' health and/or employment) and level of lockdown such as
quarantine, physical distancing, voluntary or mandatory isolation,
working from home, and shelter-in-place/stay-at-home orders.
2.2.3 | Impact of COVID-19 on eating disorders
Questions about COVID-19-related concerns on eating disorders cap-
tured the previous 2-week timeframe. A 4-point Likert-scale asked
participants to rate their level of concern about access to and afford-
ability of food and treatment, and worsening of eating disorder symp-
toms due to a lack of structure, changes in the social support
environment, and time spent living in a triggering environment. The
survey also assessed the impact of COVID-19 on specific eating disor-
der symptoms (e.g., “I have binged on food that I [or my family] have
stockpiled”). These items were combined to create a mean impact
score (Cronbach's α = .77). Free-text items queried details on addi-
tional eating disorder-related concerns and any positive changes in
their eating disorder or symptoms associated with the pandemic
(if applicable).
2.2.4 | Impact of COVID-19 on general physical
and mental well-being
A 7-point Likert scale addressed the extent to which participants were
worried about exposure to and/or contracting COVID-19. Relevant
domains included: worry about self or others, worry about physical
and/or mental health, and changes in overall anxiety levels since the
start of the pandemic. Principal components analysis suggested these
items loaded onto one component, so a total worry score was calcu-
lated (Cronbach's α = .79). The Generalized Anxiety Disorder 7-Item
Scale (GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 2006) assessed anx-
iety symptoms, and has demonstrated excellent psychometric proper-
ties (Löwe et al., 2008; Strandskov et al., 2017; Weigel, Konig, Gumz,
Löwe, & Brettschneider, 2016; Weigel, Löwe, & Kohlmann, 2019). A
score ≥10 is a positive screen for GAD (Spitzer et al., 2006). The survey
also assessed whether participants had experienced a change in their
levels of anxiety since the end of 2019, whether this change was due
to COVID-19, and any positive changes in their lives related to COVID-
19 circumstances.
2.2.5 | Impact of COVID-19 on eating disorder
treatment
We assessed COVID-19-related changes to eating disorder treatment
modality, and for those currently receiving treatment, the frequency
of sessions/contacts and perception of the quality of treatment. One
free-text item inquired about the participants' perceived greatest
treatment needs.
2.3 | Statistical analysis
Data from the US and NL were analyzed separately. We first report
descriptives of the demographics, clinical characteristics, and COVID-
19 exposure and situational circumstances. We assessed the different
sections (effects of COVID-19 on eating disorder, eating disorder
treatment, and general physical and mental wellbeing) by a descriptive
analysis of the quantitative survey items. We then conducted one-
way analyses of covariance (ANCOVA) to explore differences
between groups (defined later) on continuous items from the various
questionnaire sections, controlling for biological sex (male or female,
intersex excluded), age, and day of study enrollment. Logistic regres-
sion was used for nominal variables. We used the following category
definitions for group comparisons: (a) although individuals could indi-
cate as many eating disorders as they have experienced in their life, in
currently ill participants for the purposes of analysis we created hier-
archical lifetime diagnostic categories (i.e., a person was only included
in one category in the order of AN, BN, BED, other eating disorders
[OED]); (b) access to treatment (experiencing difficulties accessing
one's treatment provider vs. not having difficulties); (c) eating disorder
status (currently ill vs. past eating disorder); and (d) level of lockdown.
As the a priori goals of the study were to conduct a broad analysis of
areas of concern of patients with eating disorders in order to inform
providers globally about healthcare service needs, we intentionally did
not correct for multiple comparisons.
The US and Dutch free text responses were coded independently
(EvF in NL and CMP and CMB in the US). All responses to each free
text question were reviewed, counted, and grouped into categories,
which were then grouped in themes. Themes were then ranked based
on the number of individuals providing comments in that theme.
Given our goal of providing strictly descriptive results, we did not
undertake formal efforts at establishing a coding scheme.
3 | RESULTS
3.1 | Quantitative results
3.1.1 | Sociodemographic and illness
characteristics
Table 1 presents demographic information for the US (N = 511) and
NL (N = 510) samples, which were very similar. The mean age was
young adult, ranging from 16 to over 60, and participants were pre-
dominantly female, and currently ill or symptomatic. US participants
were well-distributed from across the country (Tables 1 and S1). In both
countries, the majority of participants reported a diagnosis of AN. The
next most common lifetime diagnoses were BN, BED, atypical AN, and
other specified feeding or eating disorder/eating disorder not otherwise
specified (OSFED/EDNOS), with different distributions between coun-
tries. Less common were ARFID, purging disorder, and night-eating
syndrome. A full 56% of US and 34% of NL participants reported multi-
ple lifetime eating disorder diagnoses, consistent with the known diag-
nostic fluctuation of these disorders (Schaumberg et al., 2019). Slightly
over half of participants in both samples reported being in treatment
when COVID-19 struck. We excluded sex as a covariate for NL ana-
lyses, because of the small number (N = 4) male participants.
3.1.2 | COVID-19 exposure
Table 2 presents information on extent of exposure to COVID-19. In
the US, virtually all participants had been impacted by COVID-19 with
99% reported practicing physical distancing. Only 1% reported having
a COVID-19 diagnosis, but many more reported some degree of self-
isolation, quarantine, or working from home. Seven percent of respon-
dents reported family members who had been infected and 25%
reported a family member having lost employment due to COVID-19.
The Dutch sample showed a similar pattern—98% reported practicing
physical distancing and between one third and half of the participants
reported voluntary self-isolation or working from home. In NL, 2% of
the respondents reported having a COVID-19 diagnosis, 13%
reported family members who had become physically ill, and 6%
reported a family member having lost employment.
3.1.3 | COVID-19-related impact on eating
disorder illness
We describe the results for the whole sample combining those who
endorsed “somewhat” or “very concerned” on items about eating






Age 30.61 (9.37) —
16–21 years 63 (12%) 127 (25%)
22–29 years 230 (45%) 219 (43%)
30–39 years 133 (26%) 111 (22%)
40–49 years 57 (11%) 27 (5%)
50+ years 27 (5%) 26 (5%)
Biological sex
Female 495 (97%) 506 (99%)
Male 14 (3%) 4 (1%)
Intersex 2 (0.5%) 0
Gender identity
Female 484 (95%) 498 (98%)
Male 13 (3%) 9 (2%)
Nonbinary/gender fluid/other 14 (2%) 3 (0.6%)
Region (United States)
South 151 (30%) —
Northeast 120 (23%) —
West 109 (21%) —
Midwest 96 (19%) —
Lifetime eating disordersa
AN 318 (62%) 347 (68%)
BN 178 (35%) 117 (23%)
BED 156 (31%) 60 (12%)
Atypical AN 100 (20%) 103 (20%)
OSFED/EDNOS 122 (24%) 70 (14%)
Purging disorder 38 (7%) 9 (2%)
ARFID 34 (7%) 2 (0.4%)
Night-eating syndrome 20 (4%) 5 (1%)
Currently have an ED 474 (93%) 468 (92%)
Note: Percentages on available data are given when there are missing data.
Values are Ns and percentages or means and SDs. Age was assessed via
age band intervals in the Netherlands. US sample numbers by state are
given in Table S1.
aPercentages add to over 100 in each country as participants could indi-
cate more than one lifetime eating disorder.





COVID-19 diagnosis 7 (1%) 9 (2%)
COVID-19 exposure 29 (6%) 40 (8%)
Quarantined 212 (42%) 88 (18%)
Practicing physical distancing 501 (99%) 490 (98%)
In voluntary self-isolation 221 (44%) 151 (30%)
In mandatory self-isolation 54 (11%) 33 (7%)




Family member physically ill from
COVID-19
35 (7%) 67 (13%)
Family member hospitalized
because of COVID-19
9 (2%) 18 (4%)
Family member in isolation/
quarantine
131 (26%) 71 (14%)
Family member lost job because
of COVID-19
126 (25%) 33 (6%)
Note: Percentages on available data are given when there are missing data.
Values are Ns and percentages. US missing data on individual items ranged
from 0% (N = 0) to 4.1% (N = 21) and NL missing data on individual items
ranged from 0% (N = 0) to 7.6% (N = 39).
disorder concerns (Table 3) and “frequently” or “daily or more” on
items about eating disorder illness behaviors (Table 4). The most prev-
alent concerns were parallel in both countries. Foremost, 79% (US,
N = 397) and 66% (NL, N = 331) of respondents were concerned
about worsening of the eating disorder due to lack of structure. Fur-
thermore, respondents were concerned about worsening of the eating
disorder due to being in a triggering environment (US 58%; NL 57%)
or lack of social support (US 59%; NL 48%), and being unable to
access food consistent with their meal plan (US 61%; NL 36%). Con-
cerns about having access to enough food or not being able to afford
food or treatment were less commonly endorsed in both countries.
Descriptive data showed that the greatest impact of COVID-19 on
eating disorder behaviors for US participants was in the domain of
feeling anxious about not being able to exercise (57%). This question
was not asked of NL participants. Over one third of participants in
both countries reported worsening of dietary restriction and compen-
satory behaviors. Regular binge eating on stockpiled food was
reported by 23% of respondents in the US and 14% in NL.
Individuals with past eating disorders (i.e., not currently symptom-
atic) (US N = 37; NL N = 39) also expressed concerns. These










I have been concerned about having access to
enough food (e.g., unable to go to a grocery store
regularly, unable to leave home, etc.)
US 31 31 26 13
NL 46 33 15 6
I have been concerned about accessing foods that
are consistent with my current meal plan/style of
eating
US 15 24 30 31
NL 37 27 23 14
I have been concerned about worsening of my eating
disorder due to a lack of structure
US 7 14 26 53
NL 13 21 30 36
I have been concerned about worsening of my eating
disorder due to a lack of social support
US 23 18 27 32
NL 24 27 24 24
I have been concerned about worsening of my eating
disorder due to increased time living in a triggering
environment
US 20 22 19 39
NL 23 19 31 26
I have been concerned about being able to afford
the food I need for recovery due to loss of income
related to COVID-19
US 63 19 10 8
NL 74 16 7 3
I have been concerned about being able to afford
eating disorder treatment due to loss of income
related to COVID-19
US 63 15 9 12
NL 84 8 5 3
Note: Percentages on available data are given. US missing data on individual items ranged from 0% (N = 0) to 0.8% (N = 4) and NL missing data on individual
items was 2.2% (N = 11).
Abbreviations: NL, Netherlands; US, United States.
TABLE 4 Impact of COVID-19 on eating disorder behaviors (United States: N = 511, Netherlands: N = 510)
Items Country Not at all (%) Once or twice (%) Frequently (%) Daily or more (%)
In the past 2 weeks, I have binged on food that I (or my family
or roommate) have stockpiled
US 51 26 17 6
NL 71 15 9 5
In the past 2 weeks, I have restricted my intake more because
of COVID-19-related factors
US 23 28 29 19
NL 36 24 25 14
In the past 2 weeks, I have engaged in more compensatory
behaviors (e.g., self-induced vomiting, excessive exercise,
misuse of laxatives and/or water pills) because of COVID-
19-related factors
US 43 22 20 15
NL 38 24 23 15
In the past 2 weeks, I have felt anxious about not being able to
exercise
US 18 25 29 28
NL — — — —
Note: NL participants were not asked the question about exercise. Percentages on available data are given. US missing data on individual items ranged from
1% (N = 5) to 1.2% (N = 6) and NL missing data on individual items was 3.5% (N = 18).
Abbreviations: NL, Netherlands; US, United States.
participants reported concerns in a number of areas: worsening of the
eating disorder due to a lack of structure (US 30%; NL 28%), increased
time spent in a triggering environment (US 30%; NL 10%), access to
food consistent with meal plan (US 32%; NL 3%), and having access to
enough food (US 24%; NL 3%). They also reported worsening and fre-
quent anxiety about exercise (US 35%; not asked in NL), restriction of
intake (US 13%; NL 13%), and compensatory behaviors (US 5%;
NL 3%).
Comparisons in lifetime diagnostic subgroups
In both countries, many group differences emerged on the eating dis-
order concern and illness behavior questions that were generally con-
sistent with diagnostic characteristics (ps < .05). For example, the AN
group reported significantly greater concerns about accessing foods
consistent with their meal plan and a greater worsening of dietary
restriction. The BED and BN groups reported more frequent binge
eating of stockpiled food. The results on the individual items are
shown in Tables S2 and S3.
Comparisons by treatment status
Participants self-reported their treatment status and results are shown
in Table 6. In the US, participants who reported difficulty accessing
their treatment provider reported higher mean eating disorder impacts
(N = 32, M = 2.69, SD = 0.52) compared to those who reported that
they had received face-to-face or online/tele-health treatment
(N = 243, M = 2.40, SD = 0.58), F(1,273) = 6.94, p = .01. In NL, there
were no differences between these groups (difficulty assessing
treatment: N = 24, M = 2.08, SD = 0.62; still receiving care: N = 235,
M = 2.13, SD = 0.53), F(1, 252) = 0.12, p = .91. Notably, 47% of
patients in the US and 74% in NL rated their treatment in the last
2 weeks as somewhat or much worse than usual.
Other comparisons
Comparisons of eating disorder symptomatology by illness status (cur-
rently ill vs. individuals with past eating disorders) and level of lock-
down can be found in the Supporting Information.
3.1.4 | COVID-19-related impact on general
physical and mental well-being
Table 5 presents items on the impact of COVID-19 on physical and
mental health and any positive changes that have occurred. The
majority of US and NL participants were somewhat to very worried
about the impact of COVID-19 on their physical health (US 70%; NL
66%), but more reported concerns about the impact of COVID-19 on
their mental health (US 86%; NL 88%). The mean score on the five
COVID-19 worry items was 4.56 (SD = 1.24) for the US sample and
4.52 (SD = 1.17) in the NL sample which were between the scale
anchors 4 = “somewhat worried” and 7 = “very worried”. Half of the
US participants and  40% of the NL participants reported that the
COVID-19 situation had led to positive changes in their life.
The percentage of individuals screening positive for GAD was
68% (N = 328) in the US and 63% (N = 296) in NL. Mean GAD scores
TABLE 5 Impact of COVID-19 on general physical and mental well-being (United States: N = 511, Netherlands: N = 510)
Items Country Response options
How worried are you about being
infected yourself?
1 = not worried at all 2 3 4 = somewhat worried 5 6 7 = very worried
US (%) 14 17 10 27 13 8 11
NL (%) 20 17 8 21 20 10 5
How worried are you about others
being infected?
US (%) 2 3 5 24 16 20 30
NL (%) 3 4 4 13 32 26 19
How worried are you that your
physical health could be
influenced by coronavirus
(COVID-19)?
US (%) 9 11 10 28 16 10 16
NL (%) 13 13 7 19 19 16 12
How worried are you that your
mental health could be
influenced by coronavirus
(COVID-19)?
US (%) 3 5 6 13 15 21 37
NL (%) 4 3 3 10 26 25 27
How much of your day are you
thinking about COVID-19?
1 = none at all 2 3 4 = about half the day 5 6 7 = all day long
US (%) 1 17 22 23 16 14 6
NL (%) 0.2 9 19 25 25 15 7
Has the COVID-19 situation led
to any positive changes in your
life?
1 = not at all 2 3 4 = some positive changes 5 6 7 = several positive changes
US (%) 19 17 15 35 6 3 5
NL (%) 28 16 17 18 16 4 1
Note: Percentages on available data are given. US missing data on individual items ranged from 3.9% (N = 20) to 4.5% (N = 23) and NL missing data on indi-
vidual items was 7.7% (N = 39).
Abbreviations: NL, Netherlands; US, United States.
were 12.61 (SD = 5.60) and 11.83 (SD = 5.41), respectively. The major-
ity of participants (US 80%; NL 65%) reported an increase in anxiety
levels since the end of 2019, and only 0.2% (US) and 3% (NL) of this
group reported that this change in anxiety was not at all due to
COVID-19.
3.1.5 | COVID-19-related impact on eating
disorder treatment
Table 6 presents treatment status over the past 2 weeks (Table 6).
Most respondents had transitioned to online/tele-health care
(US 45%; NL 42%), with smaller numbers still receiving face-to-face
care (US 3%; NL 6%), or not having been able to engage with their
provider at all (US 6%; NL 5%). Consistent with the literature, high
numbers of respondents were not receiving any eating disorders
treatment (US 45%; NL 47%). Comparisons of the impact of COVID-
19 on eating disorder treatment by diagnostic subgroup and level of
lockdown can be found in the Supporting Information.
Comparisons in currently ill versus past ill individuals
In both countries, participants reporting a current eating disorder (US
N = 474, 93%; NL N = 468, 92%) had a significantly higher mean
worry score (US F[1, 484] = 5.28, p = .02); NL (F[1, 464] = 5.96,
p = .02) than those with past eating disorders. The mean worry scores
were 4.59 (SD = 1.24) for those with a current eating disorder versus
4.11 (SD = 1.22) (US) for those with a past eating disorder—in NL,
these scores were 4.56 (SD = 1.17) versus 4.05 (SD = 1.01). Likewise,
those with a current eating disorder had a significantly higher GAD-7
score (US F[1, 481] = 11.78, p < .001; NL F[1, 460] = 16.79, p < .001)
with a mean of 12.87 (SD = 5.54) versus 9.62 (SD = 5.36) (NL scores
were 12.10 [SD = 5.37] vs. 8.43 [SD = 4.81]). The percentages screen-
ing positive for GAD were 70% (US) and 66% (NL) of participants with
current eating disorders compared with 41% (US) and 37% (NL) of
those with past eating disorders (US χ2(1) = 13.43, p < .001; NL
χ2(1) = 11.23, p < .001).
Comparisons by treatment status
Among those who were receiving treatment, there were no significant
differences in mean worry score between those who reported that
they had not been able to engage with their treatment provider at all
(US N = 29, 11%; NL N = 24, 9%) versus those who reported continu-
ity of care in the form of face-to-face or online/tele-health treatment
(US N = 239, 89%; NL N = 235, 91%), (US F[1,266] = 0.01, p = .93; NL
F[1,244] = 0.18, p = .67). The mean worry score was 4.63 (SD = 1.18)
for those having difficulty with treatment access versus 4.65
(SD = 1.19) for those reporting continuity of treatment, and 4.7
(SD = 1.14) versus 4.5 (SD = 1.19) in NL. There were no significant dif-
ferences in GAD-7 scores in both countries (US F[1,264] = 0.01,
p = .93; NL F[1, 241] = 1.49, p = .22). The mean GAD-7 score was
12.86 (SD = 6.19) for those having difficulty with treatment access
versus 12.96 (SD = 5.41) for those reporting continuity of care, and













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Comparisons of the impact of COVID-19 on general physical and
mental well-being by lifetime diagnostic subgroups and level of lock-
down can be found in Supporting Information.
3.2 | Qualitative results
A series of open-ended survey questions asked participants to
describe (a) any positive changes in their eating disorder; (b) treatment
needs; (c) other concerns not queried elsewhere in the survey; and (d)
any positive changes the COVID-19 situation had produced in their
lives (Tables 7 and 8).
A positive consequence of the changes due to COVID-19
reported by respondents was a perceived increase in social support
that helped challenge their eating disorder behaviors and increase
motivation to recover. Their greatest treatment need was for more
structure, face-to-face treatment and someone to talk to (NL only),
meal support, and nutritional guidance (US only). Other eating
disorder-related concerns differed by country. In the US, exposure to
toxic social media, increased suicidality and substance use, and safe
access to higher levels of care were dominant themes. In NL, respon-
dents' main concerns were fear of gaining weight, increased desire to
exercise, and a fear of what would happen were they to contract
COVID-19. In terms of positive changes in their life, participants in
both countries valued the increased connection with family and fri-
ends. The Dutch participants highlighted feeling more relaxed and an
increased motivation to work on recovery. Family meals and spiritual
and meditative practices were a main theme mentioned by US
respondents.
4 | DISCUSSION
We describe the early impact of COVID-19 and treatment needs in
patients with self-reported eating disorders in the US and NL. At the
time of the study launch, the US had been in some degree of lock-
down for approximately 3 to 5 weeks. In NL, restrictions had been
underway for approximately 1 month. Although fairly few participants
were directly affected by COVID-19, the overwhelming majority were
indirectly affected, anxiety levels were elevated, and concerns were
high regarding the impact of COVID-19-related factors on their eating
disorder and on their mental health in general.
Consequences of the lockdown measures—a lack of structure,
increased time spent in a triggering environment, lack of social
support—were common concerns. Additionally, worsening of eating
disorder behaviors was broadly consistent with respondents' self-
reported eating disorder diagnosis (e.g., greater restriction in AN;
increased binge eating in BN and BED). US participants were particu-
larly anxious about not being able to exercise. Of note, even those
who were not currently symptomatic endorsed some degree of con-
cern indicating a heightened vulnerability for relapse.
Our results align with other studies showing worsening anxiety
during COVID-19 (Fowers & Wan, 2020). Mean GAD-7 scores were
substantially higher than typical in the general population during non-
pandemic circumstances (Löwe et al., 2008) (N = 5,030, M = 2.97,
95% CI = 2.86–3.07), but on par with scores in both general psychiat-
ric disorder and eating disorder samples (Donker, van Straten,
Marks, & Cuijpers, 2011; Weigel et al., 2016). To our knowledge,
GAD-7 has not been assessed in the general population in the US or
NL during the COVID-19 pandemic for comparison.
Encouragingly, more than one-third (US 49%; NL 40%) of partici-
pants identified that COVID-19 had led to positive changes in their
life. Many reported a sense of connection with family and friends, an
ability to focus on recovery-oriented goals, and engagement in adap-
tive coping skills. That respondents were able to name positive effects
of this pandemic in addition to acknowledging the deleterious effects
it has had on their eating disorder highlights the complex nature of
individuals' experiences.
We were particularly interested in ascertaining participants' percep-
tions of treatment during COVID-19. Unfortunately, nearly half of both
samples reported not currently receiving treatment for their eating disor-
der (despite the majority endorsing current symptoms). This is consistent
with many previous reports indicating that eating disorders are often
underdetected and undertreated (Hart, Granillo, Jorm, & Paxton, 2011).
For those who were in care, most had transitioned to telehealth services
at a similar frequency to previous face-to-face sessions. However, the
transition was not without challenges. In our sample, 47% of US respon-
dents and 74% of NL respondents reported that the quality of their
treatment had been “somewhat” or “much” worse than usual. It is not
clear what influenced this perception, and we underscore that the survey
was deployed at a time when many clinicians were just making the tran-
sition to remote care. Follow-up surveys will allow us to address whether
quality of remote care continues to be a concern.
To our knowledge, this is the first large-scale study to capture
concerns of individuals with eating disorders during COVID-19.
Our rapid deployment had limitations. First, eating disorder diag-
noses were self-reported as interviews were not feasible in the
timeframe. Second, despite many striking similarities, differences
between the US and NL emerged in terms of sample composition
as well as the countries' approach to pandemic control—with the
NL strategy being more comprehensive and uniform and the US
being more fragmented. Moreover, differences in these strategies
and stage of the pandemic at deployment could affect responses.
Our use of convenience sampling could introduce bias, as individ-
uals who were most worried/concerned might be more inclined to
participate. Some of our questions may have used language that
could be interpreted in multiple ways such as “triggering environ-
ment” and “lack of structure.” We also mistakenly omitted the
question on race/ethnicity, which we will critically include in sub-
sequent waves, especially given the disparity in COVID-19 out-
comes across racial and ethnic groups (Webb Hooper, Napoles, &
Perez-Stable, 2020). Finally, our use of predetermined questions,
did not allow for an unbiased survey of respondents' concerns;
however, we hope that the inclusion of free text questions
encouraged sharing of both negative and positive experiences.
Although outside of the scope of the present study, given that
many individuals with eating disorders returned to their families
of origin during lockdown, it would be of value to document the
impact of COVID-19 on carers' and family members' experiences
particularly with relation to stress, burnout, mealtimes, and
healthcare provider support.
In summary, individuals with eating disorders may be
experiencing a worsening of symptoms and those with past eating
disorders may be vulnerable for relapse during COVID-19.
Although these data are primarily descriptive, we aim to provide
preliminary guidance to healthcare providers about ways in which
they might be of assistance during this time. Both quantitative
and qualitative data underscore the call for structure, especially
around meals. Clinicians should assess what structures do exist
and be innovative in developing strategies to help patients struc-
ture their daily schedules and meals.
Given the unclear level of satisfaction with early delivery of
telehealth, clinicians should be direct in addressing what is working
and what is not working in terms of telehealth sessions, and not
assume that they are equivalent to face-to-face encounters. Frank dis-
cussions might allow patient and provider to work collaboratively to
ensure care is being delivered effectively and compassionately. Finally,
given the uncertain nature of this pandemic and the ways in which it
will affect our lives, it is important to remain nimble both in the
approach to delivering care and the extent to which care may need to
be modified in light of novel and ever-changing stressors. Assessing
and harnessing factors that have led to positive changes in patients'
lives and their eating disorder, such as greater social support, family
mealtimes, and opportunities for self-care may aid with treatment
planning. The challenges in delivering eating disorders care during
COVID-19 are numerous; however, consistent collaborative efforts
between patient and provider may help stem the tide of worsening
symptomatology and allow patients to continue to make progress
toward recovery.
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